These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 23440878

  • 1. Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.
    Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, van Zijl PC, Blakeley JO.
    J Magn Reson Imaging; 2013 Nov; 38(5):1119-28. PubMed ID: 23440878
    [Abstract] [Full Text] [Related]

  • 2. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY, Jones CK, Hua J, Yadav N, Agarwal S, Zhou J, van Zijl PC, Pillai JJ.
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B0 correction.
    Togao O, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, Yoneyama M, Honda H.
    Magn Reson Med; 2017 Jun; 77(6):2272-2279. PubMed ID: 27385636
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Scan-rescan reproducibility of parallel transmission based amide proton transfer imaging of brain tumors.
    Togao O, Hiwatashi A, Keupp J, Yamashita K, Kikuchi K, Yoshiura T, Suzuki Y, Kruiskamp MJ, Sagiyama K, Takahashi M, Honda H.
    J Magn Reson Imaging; 2015 Nov; 42(5):1346-53. PubMed ID: 25828573
    [Abstract] [Full Text] [Related]

  • 7. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O, Hiwatashi A, Yamashita K, Kikuchi K, Keupp J, Yoshimoto K, Kuga D, Yoneyama M, Suzuki SO, Iwaki T, Takahashi M, Iihara K, Honda H.
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantification of amide proton transfer effect pre- and post-gadolinium contrast agent administration.
    Tee YK, Donahue MJ, Harston GW, Payne SJ, Chappell MA.
    J Magn Reson Imaging; 2014 Oct; 40(4):832-8. PubMed ID: 24214526
    [Abstract] [Full Text] [Related]

  • 10. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
    Wu Y, Chen Y, Zhao Y, Yang S, Zhao J, Zhou J, Chen Z, Sun PZ, Zheng H.
    Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
    [Abstract] [Full Text] [Related]

  • 11. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast.
    Wen Z, Hu S, Huang F, Wang X, Guo L, Quan X, Wang S, Zhou J.
    Neuroimage; 2010 Jun; 51(2):616-22. PubMed ID: 20188197
    [Abstract] [Full Text] [Related]

  • 12. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, Suzuki Y, Suzuki SO, Iwaki T, Hata N, Mizoguchi M, Yoshimoto K, Sagiyama K, Takahashi M, Honda H.
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [Abstract] [Full Text] [Related]

  • 13. Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.
    Heo HY, Zhang Y, Jiang S, Lee DH, Zhou J.
    Magn Reson Med; 2016 Apr; 75(4):1630-9. PubMed ID: 26033553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A, Gupta RK, Singh A.
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [Abstract] [Full Text] [Related]

  • 17. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C, Liu C, Zhao L, Jiang J, Zhang J, Li S, Zhu W, Wang J.
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [Abstract] [Full Text] [Related]

  • 18. Amide proton transfer imaging of human brain tumors at 3T.
    Jones CK, Schlosser MJ, van Zijl PC, Pomper MG, Golay X, Zhou J.
    Magn Reson Med; 2006 Sep; 56(3):585-92. PubMed ID: 16892186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS, Ahn SS, Lee SK, Chang JH, Kang SG, Kim SH, Zhou J.
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.